Unither will acquire UCB pharmaceutical plant in Rochester, New york, US.

Unither will acquire UCB pharmaceutical plant in Rochester, New york, US.
 
The plant employs 250 people and mainly manufacturers liquid pharmaceutical products. This acquisition is a part of Unither's strategy to become a pharmaceutical global player and particularly in BFS technology.
 
The Acquisition Agreement states that Unither will continue manufacturing UCB products and all Rochester's employees will be offered the opportunity to work for Unither. While continuing manufacturing UCB products, Unither intends to install as soon as possible BFS and stick-pack technologies in Rochester's plant in order to provide its clients or US prospects with locally-made products.
 
The transaction is expected to be completed in the fourth quarter of this year.

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.